Singh, S. et al. Monoclonal antibodies: a review. Curr. Clin. Pharmacol. 13, 85–99 (2018).
Google ScholarÂ
Khetan, R. et al. Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics. MAbs 14, 2020082 (2022).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Akbar, R. et al. Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies. MAbs 14, 2008790 (2022).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Laustsen, A. H., Greiff, V., Karatt-Vellatt, A., Muyldermans, S. & Jenkins, T. P. Animal immunization, in vitro display technologies, and machine learning for antibody discovery. Trends Biotechnol. 39, 1263–1273 (2021).Wilman, W. et al. Machine-designed biotherapeutics: opportunities, feasibility and advantages of deep learning in computational antibody discovery. Brief. Bioinform. 23, bbac267 (2022).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Lu, R.-M. et al. Development of therapeutic antibodies for the treatment of diseases. J. Biomed. Sci. 27, 1 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Raybould, M. I. J. et al. Five computational developability guidelines for therapeutic antibody profiling. Proc. Natl Acad. Sci. USA. 116, 4025–4030 (2019).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Xu, Y. et al. Structure, heterogeneity and developability assessment of therapeutic antibodies. MAbs 11, 239–264 (2019).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Hummer, A. M., Abanades, B. & Deane, C. M. Advances in computational structure-based antibody design. Curr. Opin. Struct. Biol. 74, 102379 (2022).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Ahmed, L., Gupta, P. & Martin, K. P. Intrinsic physicochemical profile of marketed antibody-based biotherapeutics. Proc. Natl Acad. Sci. USA 118, e2020577118 (2021).Narayanan, H. et al. Design of biopharmaceutical formulations accelerated by machine learning. Mol. Pharm. 18, 3843–3853 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Sankar, K. et al. A descriptor set for quantitative structure-property relationship prediction in biologics. Mol. Inform. 41, e2100240 (2022).Zarzar, J. et al. High concentration formulation developability approaches and considerations. MAbs 15, 2211185 (2023).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Harmalkar, A. et al. Toward generalizable prediction of antibody thermostability using machine learning on sequence and structure features. MAbs 15, 2163584 (2023).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Zhang, W. et al. Developability assessment at early-stage discovery to enable development of antibody-derived therapeutics. Antib. Ther. 6, 13–29 (2023).CASÂ
PubMedÂ
Google ScholarÂ
Carter, P. J. & Lazar, G. A. Next generation antibody drugs: pursuit of the ‘high-hanging fruit’. Nat. Rev. Drug Discov. 17, 197–223 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Jain, T. et al. Biophysical properties of the clinical-stage antibody landscape. Proc. Natl Acad. Sci. USA 114, 944–949 (2017).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Evers, A., Malhotra, S. & Sood, V. D. In silico approaches to deliver better antibodies by design: the past, the present and the future. arXiv https://doi.org/10.48550/arXiv.2305.07488 (2023).Harvey, E. P. et al. An in silico method to assess antibody fragment polyreactivity. Nat. Commun. 13, 7554 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Fernández-Quintero, M. L. et al. Assessing developability early in the discovery process for novel biologics. MAbs 15, 2171248 (2023).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Khan, A. et al. Toward real-world automated antibody design with combinatorial Bayesian optimization. Cell Rep. Methods 3, 100374 (2023).Ausserwöger, H. et al. Non-specificity as the sticky problem in therapeutic antibody development. Nat. Rev. Chem. 6, 844–861 (2022).Mieczkowski, C. et al. Blueprint for antibody biologics developability. MAbs 15, 2185924 (2023).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kingsbury, J. S. et al. A single molecular descriptor to predict solution behavior of therapeutic antibodies. Sci. Adv. 6, eabb0372 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Wolf Pérez, A.-M. et al. In vitro and in silico assessment of the developability of a designed monoclonal antibody library. MAbs 11, 388–400 (2019).Han, X., Shih, J., Lin, Y., Chai, Q. & Cramer, S. M. Development of QSAR models for in silico screening of antibody solubility. MAbs 14, 2062807 (2022).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Widatalla, T., Rollins, Z., Chen, M.-T., Waight, A. & Cheng, A. C. AbPROP: Language and Graph Deep Learning for Antibody Property Prediction. https://icml-compbio.github.io/2023/papers/WCBICML2023_paper53.pdf (2023).Licari, G. et al. Embedding dynamics in intrinsic physicochemical profiles of market-stage antibody-based biotherapeutics. Mol. Pharm. 2, 1096–1111 (2022).Makowski, E. K. et al. Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning. Nat. Biomed. Eng. 8, 45–56 (2023).Jain, T., Boland, T. & Vásquez, M. Identifying developability risks for clinical progression of antibodies using high-throughput in vitro and in silico approaches. MAbs 15, 2200540 (2023).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Waight, A. B. et al. A machine learning strategy for the identification of key in silico descriptors and prediction models for IgG monoclonal antibody developability properties. MAbs 15, 2248671 (2023).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Park, E. & Izadi, S. Molecular surface descriptors to predict antibody developability. bioRxiv https://doi.org/10.1101/2023.07.18.549448 (2023).Bauer, J. et al. How can we discover developable antibody-based biotherapeutics? Front. Mol. Biosci. 10, 1221626 (2023).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Makowski, E. K. et al. Reduction of monoclonal antibody viscosity using interpretable machine learning. MAbs 16, 2303781 (2024).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Thrift, W. J. et al. Graph-pMHC: graph neural network approach to MHC class II peptide presentation and antibody immunogenicity. Brief. Bioinform. 25, bbae123 (2024).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Raybould, M. I. J., Turnbull, O. M., Suter, A., Guloglu, B. & Deane, C. M. Contextualising the developability risk of antibodies with lambda light chains using enhanced therapeutic antibody profiling. Commun. Biol. 7, 62 (2024).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Leem, J., Dunbar, J., Georges, G., Shi, J. & Deane, C. M. ABodyBuilder: Automated antibody structure prediction with data–driven accuracy estimation. MAbs 8, 1259–1268 (2016).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Abanades, B. et al. ImmuneBuilder: Deep-learning models for predicting the structures of immune proteins. Commun. Biol. 6, 575 (2023).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Ruffolo, J. A., Chu, L.-S., Mahajan, S. P. & Gray, J. J. Fast, accurate antibody structure prediction from deep learning on massive set of natural antibodies. Nat. Commun. 14, 2389 (2023).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Reynisson, B. et al. Improved prediction of MHC II antigen presentation through integration and motif deconvolution of mass spectrometry MHC eluted. Ligand Data. J. Proteome Res. 19, 2304–2315 (2020).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Thorsteinson, N., Gunn, J. R., Kelly, K., Long, W. & Labute, P. Structure-based charge calculations for predicting isoelectric point, viscosity, clearance, and profiling antibody therapeutics. MAbs 13, 1981805 (2021).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Hutchinson, M. et al. Enhancement of antibody thermostability and affinity by computational design in the absence of antigen. bioRxiv https://doi.org/10.1101/2023.12.19.572421 (2023).Evers, A. et al. Engineering hydrophobicity and manufacturability for optimized biparatopic antibody–drug conjugates targeting c-MET. MAbs 16, 2302386 (2024).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
SatÅ‚awa, T. et al. LAP: Liability antibody profiler by sequence & structural mapping of natural and therapeutic antibodies. PLoS Comput. Biol. 20, e1011881 (2024).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Feng, J., Jiang, M., Shih, J. & Chai, Q. Antibody apparent solubility prediction from sequence by transfer learning. iScience 25, 105173 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
PudžiuvelytÄ—, I. et al. TemStaPro: protein thermostability prediction using sequence representations from protein language models. Bioinformatics 40, btae157 (2024).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Manz, R. A., Hauser, A. E., Hiepe, F. & Radbruch, A. Maintenance of serum antibody levels. Annu. Rev. Immunol. 23, 367–386 (2005).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Goodnow, C. C., Vinuesa, C. G., Randall, K. L., Mackay, F. & Brink, R. Control systems and decision making for antibody production. Nat. Immunol. 11, 681–688 (2010).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Shehata, L. et al. Affinity maturation enhances antibody specificity but compromises conformational stability. Cell Rep. 28, 3300–3308.e4 (2019).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Shin, J.-E. et al. Protein design and variant prediction using autoregressive generative models. Nat. Commun. 12, 2403 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Pucca, M. B. et al. History of envenoming therapy and current perspectives. Front. Immunol. 10, 1598 (2019).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Krawczyk, K., Raybould, M. I. J., Kovaltsuk, A. & Deane, C. M. Looking for therapeutic antibodies in next-generation sequencing repositories. MAbs 11, 1197–1205 (2019).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Marks, C. & Deane, C. M. How repertoire data are changing antibody science. J. Biol. Chem. 295, 9823–9837 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Petersen, B. M. et al. Regulatory approved monoclonal antibodies contain framework mutations predicted from human antibody repertoires. Front. Immunol. 12, 728694 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Negron, C., Fang, J., McPherson, M. J., Stine, W. B. Jr & McCluskey, A. J. Separating clinical antibodies from repertoire antibodies, a path to in silico developability assessment. MAbs 14, 2080628 (2022).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Lauer, T. M. et al. Developability index: a rapid In silico tool for the screening of antibody aggregation propensity. J. Pharm. Sci. 101, 2271–2280 (2012).ArticleÂ
Google ScholarÂ
Chen, X. et al. Predicting antibody developability from sequence using machine learning. biorxiv https://doi.org/10.1101/2020.06.18.159798 (2020).Krawczyk, K., Buchanan, A. & Marcatili, P. Data mining patented antibody sequences. MAbs 13, 1892366 (2021).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Shetgaonkar, S. & Singh, A. Hybridization of artificial bee colony Aalgorithm with estimation of distribution algorithm for minimum weight dominating set problem. in ICT Systems and Sustainability (eds Tuba, M., Akashe, S., Joshi, A.) 607–619 (Springer, Singapore, 2021).Evers, A. et al. SUMO: In silico sequence assessment using multiple optimization parameters. in Genotype Phenotype Coupling: Methods and Protocols (eds Zielonka, S. & Krah, S.) 383–398 (Springer US, New York, 2023).Makowski, E. K. et al. Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space. Nat. Commun. 13, 3788 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Saltelli, A. et al. Why so many published sensitivity analyses are false: a systematic review of sensitivity analysis practices. Environ. Model. Softw. 114, 29–39 (2019).ArticleÂ
Google ScholarÂ
Balanda, K. P. & Macgillivray, H. L. Kurtosis: A critical review. Am. Stat. 42, 111–119 (1988).ArticleÂ
Google ScholarÂ
Giudicelli, V. & Lefranc, M. P. Ontology for immunogenetics: the IMGT-ONTOLOGY. Bioinformatics 15, 1047–1054 (1999).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Peres, A. et al. IGHV allele similarity clustering improves genotype inference from adaptive immune receptor repertoire sequencing data. Nucleic Acids Res. 51, e86 (2023).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Schäfer, J. & Strimmer, K. A shrinkage approach to large-scale covariance matrix estimation and implications for functional genomics. Stat. Appl. Genet. Mol. Biol. 4, Article32 (2005).ArticleÂ
PubMedÂ
Google ScholarÂ
Barroso, R., Morrison, W. I. & Morrison, L. J. Molecular dissection of the antibody response: opportunities and needs for application in cattle. Front. Immunol. 11, 1175 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Mhanna, V. et al. Adaptive immune receptor repertoire analysis. Nat. Rev. Methods Prim. 4, 1–25 (2024).
Google ScholarÂ
Sandve, G. K. & Greiff, V. Access to ground truth at unconstrained size makes simulated data as indispensable as experimental data for bioinformatics methods development and benchmarking. Bioinformatics 38, 4994–4996 (2022).Pavlović, M. et al. The immuneML ecosystem for machine learning analysis of adaptive immune receptor repertoires. Nat. Mach. Intell. 3, 936–944 (2021).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Perkins, N. J. et al. Principled approaches to missing data in epidemiologic studies. Am. J. Epidemiol. 187, 568–575 (2018).ArticleÂ
PubMedÂ
Google ScholarÂ
Hong, S. & Lynn, H. S. Accuracy of random-forest-based imputation of missing data in the presence of non-normality, non-linearity, and interaction. BMC Med. Res. Methodol. 20, 199 (2020).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Shadbahr, T. et al. The impact of imputation quality on machine learning classifiers for datasets with missing values. Commun. Med. 3, 139 (2023).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Alley, E. C., Khimulya, G., Biswas, S., AlQuraishi, M. & Church, G. M. Unified rational protein engineering with sequence-based deep representation learning. Nat. Methods 16, 1315–1322 (2019).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Meier, J. et al. Language models enable zero-shot prediction of the effects of mutations on protein function. bioRxiv https://doi.org/10.1101/2021.07.09.450648 (2021).Madani, A. et al. Large language models generate functional protein sequences across diverse families. Nat. Biotechnol. 8, 1099–1106 (2023).Nijkamp, E., Ruffolo, J., Weinstein, E. N., Naik, N. & Madani, A. ProGen2: Exploring the Boundaries of Protein Language Models. https://openreview.net (2022).Vatcheva, K. P., Lee, M., McCormick, J. B. & Rahbar, M. H. Multicollinearity in regression analyses conducted in epidemiologic studies. Epidemiology 6, 227 (2016).Azur, M. J., Stuart, E. A., Frangakis, C. & Leaf, P. J. Multiple imputation by chained equations: what is it and how does it work? Int. J. Methods Psychiatr. Res. 20, 40–49 (2011).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Waljee, A. K. et al. Comparison of imputation methods for missing laboratory data in medicine. BMJ Open 3, e002847 (2013).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Aracri, F., Giovanna Bianco, M., Quattrone, A. & Sarica, A. Imputation of missing clinical, cognitive and neuroimaging data of dementia using missForest, a random forest based algorithm. in 2023 IEEE 36th International Symposium on Computer-Based Medical Systems (CBMS) 684–688 (2023).Molnar, C. Interpretable Machine Learning, 318 (Lulu.com, 2020).Teixeira, A. A. R. et al. Simultaneous affinity maturation and developability enhancement using natural liability-free CDRs. MAbs 14, 2115200 (2022).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Tiller, T. et al. A fully synthetic human fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties. MAbs 5, 445–470 (2013).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Erasmus, M. F. et al. A single donor is sufficient to produce a highly functional in vitro antibody library. Commun. Biol. 4, 350 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Richardson, E. et al. Characterisation of the immune repertoire of a humanised transgenic mouse through immunophenotyping and high-throughput sequencing. Elife 12, e81629 (2023).Suzek, B. E. et al. UniRef clusters: a comprehensive and scalable alternative for improving sequence similarity searches. Bioinformatics 31, 926–932 (2015).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Ofer, D., Brandes, N. & Linial, M. The language of proteins: NLP, machine learning & protein sequences. Comput. Struct. Biotechnol. J. 19, 1750–1758 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Vu, M. H. et al. Linguistically inspired roadmap for building biologically reliable protein language models. Nat. Mach. Intell. 5, 485–496 (2023).Vu, M. H. et al. ImmunoLingo: Linguistics-based formalization of the antibody language. arXiv https://doi.org/10.48550/arXiv.2209.12635 (2022).Schneider, C., Raybould, M. I. J. & Deane, C. M. SAbDab in the age of biotherapeutics: updates including SAbDab-nano, the nanobody structure tracker. Nucleic Acids Res. 50, D1368–D1372 (2022).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Bradbury, A. R. M., Dübel, S., Knappik, A. & Plückthun, A. Animal- versus in vitro-derived antibodies: avoiding the extremes. MAbs 13, 1950265 (2021).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Glanville, J. et al. Deep sequencing in library selection projects: what insight does it bring? Curr. Opin. Struct. Biol. 33, 146–160 (2015).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Mason, D. M. et al. High-throughput antibody engineering in mammalian cells by CRISPR/Cas9-mediated homology-directed mutagenesis. Nucleic Acids Res. 46, 7436–7449 (2018).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Jaffe, D. B. et al. Functional antibodies exhibit light chain coherence. Nature 611, 352–357 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Burbach, S. M. & Briney, B. Improving antibody language models with native pairing. arXiv https://doi.org/10.1016/j.patter.2024.100967 (2023).Akbar, R. et al. A compact vocabulary of paratope-epitope interactions enables predictability of antibody-antigen binding. Cell Rep. 34, 108856 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Norman, R. A. et al. Computational approaches to therapeutic antibody design: established methods and emerging trends. Brief. Bioinform. 21, 1549–1567 (2020).ArticleÂ
PubMedÂ
Google ScholarÂ
Vishwakarma, P. et al. VHH structural modelling approaches: a critical review. Int. J. Mol. Sci. 23, 3721 (2022).Bailly, M. et al. Predicting antibody developability profiles through early stage discovery screening. MAbs 12, 1743053 (2020).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Schoch, A. et al. Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics. Proc. Natl Acad. Sci. USA 112, 5997–6002 (2015).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Piche-Nicholas, N. M. et al. Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics. MAbs 10, 81–94 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Grevys, A. et al. Antibody variable sequences have a pronounced effect on cellular transport and plasma half-life. iScience 25, 103746 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Prihoda, D. et al. BioPhi: A platform for antibody design, humanization, and humanness evaluation based on natural antibody repertoires and deep learning. MAbs 14, 2020203 (2022).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Marks, C., Hummer, A. M., Chin, M. & Deane, C. M. Humanization of antibodies using a machine learning approach on large-scale repertoire data. Bioinformatics 37, 4041–4047 (2021).Tennenhouse, A. et al. Computational optimization of antibody humanness and stability by systematic energy-based ranking. Nat. Biomed. Eng. 8, 30–44 (2023).Ramon, A. et al. Assessing antibody and nanobody nativeness for hit selection and humanization with AbNatiV. Nat. Mach. Intell. 6, 74–91 (2024).ArticleÂ
Google ScholarÂ
The Antibody Society. Antibody Therapeutics Approved or in Regulatory Review in the EU or US. https://www.antibodysociety.org/resources/approved-antibodies/ (2022).Tilegenova, C. et al. Dissecting the molecular basis of high viscosity of monospecific and bispecific IgG antibodies. MAbs 12, 1692764 (2020).ArticleÂ
PubMedÂ
Google ScholarÂ
Seeliger, D. et al. Boosting antibody developability through rational sequence optimization. MAbs 7, 505–515 (2015).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Mason, D. M. et al. Optimization of therapeutic antibodies by predicting antigen specificity from antibody sequence via deep learning. Nat. Biomed. Eng. 5, 600–612 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Schretter, C., Kobbelt, L. & Dehaye, P.-O. Golden ratio sequences for low-discrepancy sampling. J. Graph. Tools 16, 95–104 (2012).ArticleÂ
Google ScholarÂ
McKay, M. D., Beckman, R. J. & Conover, W. J. A comparison of three methods for selecting values of input variables in the analysis of output from a computer code. Technometrics 21, 239–245 (1979).
Google ScholarÂ
Apgar, J. R. et al. Modeling and mitigation of high-concentration antibody viscosity through structure-based computer-aided protein design. PLoS One 15, e0232713 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
van der Flier, F. J. et al. What makes the effect of protein mutations difficult to predict? bioRxiv https://doi.org/10.1101/2023.09.25.559319 (2023).Childers, M. C. & Daggett, V. Molecular dynamics methods for antibody design. in Computer-Aided Antibody Design (eds Tsumoto, K. & Kuroda, D.) 109–124 (Springer US, 2023).Knapp, B., Frantal, S., Cibena, M., Schreiner, W. & Bauer, P. Is an intuitive convergence definition of molecular dynamics simulations solely based on the root mean square deviation possible? J. Comput. Biol. 18, 997–1005 (2011).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Jaszczyszyn, I. et al. Structural modeling of antibody variable regions using deep learning—progress and perspectives on drug discovery. Front. Mol. Biosci. https://doi.org/10.3389/fmolb.2023.1214424 (2023).Kulikova, A. V. et al. Two sequence-and two structure-based ML models have learned different aspects of protein biochemistry. Sci. Rep. 13, 13280 (2023).Makowski, E. K., Chen, H.-T. & Tessier, P. M. Simplifying complex antibody engineering using machine learning. Cell Syst. 14, 667–675 (2023).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Fernández-Quintero, M. L. et al. Challenges in antibody structure prediction. MAbs 15, 2175319 (2023).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Lane, T. J. Protein structure prediction has reached the single-structure frontier. Nat. Methods 20, 170–173 (2023).Fernández-Quintero, M. L. et al. Characterizing the diversity of the CDR-H3 loop conformational ensembles in relationship to antibody binding properties. Front. Immunol. 9, 3065 (2018).ArticleÂ
PubMedÂ
Google ScholarÂ
Waibl, F. et al. Comparison of hydrophobicity scales for predicting biophysical properties of antibodies. Front Mol. Biosci. 9, 960194 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Hoerschinger, V. J. et al. PEP-patch: Electrostatics in protein-protein recognition, specificity, and antibody Ddevelopability. J. Chem. Inf. Model. 63, 6964–6971 (2023).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Eastman, P. et al. OpenMM 7: Rapid development of high performance algorithms for molecular dynamics. PLoS Comput. Biol. 13, e1005659 (2017).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Chaudhury, S., Lyskov, S. & Gray, J. J. PyRosetta: a script-based interface for implementing molecular modeling algorithms using Rosetta. Bioinformatics 26, 689–691 (2010).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kang, T. H. & Jung, S. T. Boosting therapeutic potency of antibodies by taming Fc domain functions. Exp. Mol. Med. 51, 1–9 (2019).PubMedÂ
Google ScholarÂ
Abanades, B. et al. The patent and literature antibody database (PLAbDab): an evolving reference set of functionally diverse, literature-annotated antibody sequences and structures. Nucleic Acids Res. 52, D545–D551 (2024).ArticleÂ
PubMedÂ
Google ScholarÂ
Lee, J., Han, K., Kim, J., Yu, H. & Lee, Y. Solvent: A framework for protein folding. arXiv https://doi.org/10.48550/arXiv.2307.04603 (2023).Singh, R. et al. Learning the language of antibody hypervariability. bioRxiv https://doi.org/10.1101/2023.04.26.538476 (2023).Khade, P. M., Maser, M., Gligorijevic, V. & Watkins, A. M. Mixed structure- and sequence-based approach for protein graph neural networks with application to antibody developability prediction. bioRxiv https://doi.org/10.1101/2023.06.26.546331 (2023).Akbar, R. et al. In silico proof of principle of machine learning-based antibody design at unconstrained scale. MAbs 14, 2031482 (2022).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Chen, V. et al. Best practices for interpretable machine learning in computational biology. bioRxiv https://doi.org/10.1101/2022.10.28.513978 (2022).Kovaltsuk, A. et al. Observed antibody space: a resource for data mining next-generation sequencing of antibody repertoires. J. Immunol. 201, 2502–2509 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Vázquez Bernat, N. et al. High-quality library preparation for NGS-based immunoglobulin germline gene inference and repertoire expression analysis. Front. Immunol. 10, 660 (2019).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Bolotin, D. A. et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat. Methods 12, 380–381 (2015).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Giudicelli, V. et al. From IMGT-ONTOLOGY to IMGT/HighV-QUEST for NGS immunoglobulin (IG) and T cell receptor (TR) repertoires in autoimmune and infectious diseases. Autoimmun Infec. Dis. https://doi.org/10.16966/2470-1025.103 (2015).Raybould, M. I. J. et al. Thera-SAbDab: the therapeutic structural antibody database. Nucleic Acids Res. 48, D383–D388 (2020).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Dunbar, J. & Deane, C. M. ANARCI: antigen receptor numbering and receptor classification. Bioinformatics 32, 298–300 (2016).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Osorio, D., Rondon-Villarreal, P. & Torres, R. Peptides: A Package for Data Mining of Antimicrobial Peptides. https://journal.r-project.org/archive/2015/RJ-2015-001/RJ-2015-001.pdf (2015).RStudio Team. RStudio: Integrated Development Environment for R. http://www.rstudio.com/ (2020).Kelly, S. M., Jess, T. J. & Price, N. C. How to study proteins by circular dichroism. Biochim. Biophys. Acta 1751, 119–139 (2005).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Edelhoch, H. Spectroscopic determination of tryptophan and tyrosine in proteins *. Biochemistry 6, 1948–1954 (1967).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Pace, C. N., Vajdos, F., Fee, L., Grimsley, G. & Gray, T. How to measure and predict the molar absorption coefficient of a protein. Protein Sci. 4, 2411–2423 (1995).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Chailyan, A., Marcatili, P. & Tramontano, A. The association of heavy and light chain variable domains in antibodies: implications for antigen specificity: analysis of VH-VL interface in antibodies. FEBS J. 278, 2858–2866 (2011).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Eisenberg, D., Weiss, R. M. & Terwilliger, T. C. The hydrophobic moment detects periodicity in protein hydrophobicity. Proc. Natl Acad. Sci. USA 81, 140–144 (1984).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Ikai, A. Thermostability and aliphatic index of globular proteins. J. Biochem. 88, 1895–8 (1980).Guruprasad, K., Reddy, B. V. B. & Pandit, M. W. Correlation between stability of a protein and its dipeptide composition: a novel approach for predicting in vivo stability of a protein from its primary sequence. Protein Eng. Des. Sel. 4, 155–161 (1990).ArticleÂ
CASÂ
Google ScholarÂ
Hon, J. et al. SoluProt: prediction of soluble protein expression in Escherichia coli. Bioinformatics 37, 23–28 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Word, J. M., Lovell, S. C., Richardson, J. S. & Richardson, D. C. Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation. J. Mol. Biol. 285, 1735–1747 (1999).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Brandon, C. J., Martin, B. P., McGee, K. J., Stewart, J. J. P. & Braun-Sand, S. B. An approach to creating a more realistic working model from a protein data bank entry. J. Mol. Model. 21, 3 (2015).ArticleÂ
PubMedÂ
Google ScholarÂ
Cock, P. J. A. et al. Biopython: freely available python tools for computational molecular biology and bioinformatics. Bioinformatics 25, 1422–1423 (2009).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Mitternacht, S. FreeSASA: An open source C library for solvent accessible surface area calculations. F1000Res. 5, 189 (2016).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Olsson, M. H. M., Søndergaard, C. R., Rostkowski, M. & Jensen, J. H. PROPKA3: Consistent treatment of internal and surface residues in empirical pKa predictions. J. Chem. Theory Comput. 7, 525–537 (2011).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Bakan, A., Meireles, L. M. & Bahar, I. ProDy: protein dynamics inferred from theory and experiments. Bioinformatics 27, 1575–1577 (2011).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Pilgrim, M. & Willison, S. Dive into Python 3 2nd edn, 412 (Springer, 2009).Jubb, H. C. et al. Arpeggio: A web server for calculating and visualising interatomic interactions in protein structures. J. Mol. Biol. 429, 365–371 (2017).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847–2849 (2016).Zhong, J. Csi-Greifflab/mwds_calculator. https://github.com/csi-greifflab/mwds_calculator (2023).Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Otasek, D., Morris, J. H., Bouças, J., Pico, A. R. & Demchak, B. Cytoscape automation: empowering workflow-based network analysis. Genome Biol. 20, 185 (2019).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kassambara, A. & Mundt, F. Factoextra: Extract and Visualize the Results of Multivariate Data Analyses. https://CRAN.R-project.org/package=factoextra (2020).R Core Team. R: A Language and Environment for Statistical Computing. https://www.R-project.org/ (2020).Greiff, V. et al. A minimal model of peptide binding predicts ensemble properties of serum antibodies. BMC Genomics 13, 79 (2012).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
van der Loo, M. P. J. The stringdist package for approximate string matching. R. J. 6, 111–122, https://CRAN.R-project.org/package=stringdist (2014).ArticleÂ
Google ScholarÂ
Bachmann, M. Levenshtein Python Package https://pypi.org/project/python-Levenshtein/ (2022).Pedregosa, F. et al. Scikit-learn: Machine Learning in Python. https://scikit-learn.org/stable/ (2011).Dask Development Team. Dask: Library for dynamic task scheduling. https://dask.org (2016).Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460–2461 (2010).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Kvalseth, T. O. Cautionary note about R2. Am. Stat. 39, 279–285 (1985).
Google ScholarÂ
Mayer, M. MissRanger: Fast Imputation of Missing Values. https://CRAN.R-project.org/package=missRanger (2023).Devlin, J., Chang, M.-W., Lee, K. & Toutanova, K. BERT: Pre-training of Deep Bidirectional Transformers for Language Understanding. arXiv [cs.CL] (2018).Schrödinger, L. L. C. & DeLano, W. PyMOL. https://pymol.org/ (2024).Wickham, H. Ggplot2. Wiley Interdiscip. Rev. Comput. Stat. 3, 180–185 (2011).ArticleÂ
Google ScholarÂ
Adobe Inc. Adobe Illustrator. https://www.adobe.com (2019).Ferdous, S. & Martin, A. C. R. AbDb: antibody structure database-a database of PDB-derived antibody structures. Database 2018, bay040 (2018).Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Evans, R. et al. Protein complex prediction with AlphaFold-multimer. bioRxiv https://doi.org/10.1101/2021.10.04.463034 (2022).Kuhlman, B. & Bradley, P. Advances in protein structure prediction and design. Nat. Rev. Mol. Cell Biol. 20, 681–697 (2019).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Sali, A. & Blundell, T. L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779–815 (1993).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Abraham, M. et al. GROMACS 2023.1 Manual. https://doi.org/10.5281/zenodo.7852189 (2023).Lindorff-Larsen, K. et al. Improved side-chain torsion potentials for the amber ff99SB protein force field. Proteins 78, 1950–1958 (2010).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926–935 (1983).ArticleÂ
CASÂ
Google ScholarÂ
Bekker, G.-J., Fukuda, I., Higo, J. & Kamiya, N. Mutual population-shift driven antibody-peptide binding elucidated by molecular dynamics simulations. Sci. Rep. 10, 1406 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Haug, E. J., Arora, J. S. & Matsui, K. A steepest-descent method for optimization of mechanical systems. J. Optim. Theory Appl. 19, 401–424 (1976).ArticleÂ
Google ScholarÂ
Braun, E. et al. Best practices for foundations in molecular simulations. Living J. Comput. Mol. Sci. 1, 5957 (2019).Parrinello, M. & Rahman, A. Crystal structure and pair potentials: a molecular-dynamics study. Phys. Rev. Lett. 45, 1196–1199 (1980).ArticleÂ
CASÂ
Google ScholarÂ
Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. J. Chem. Phys. 126, 014101 (2007).ArticleÂ
PubMedÂ
Google ScholarÂ
Hess, B., Bekker, H., Berendsen, H. J. C. & Fraaije, J. G. E. M. LINCS: A linear constraint solver for molecular simulations. J. Comput. Chem. 18, 1463–1472 (1997).ArticleÂ
CASÂ
Google ScholarÂ
Miyamoto, S. & Kollman, P. A. Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models. J. Comput. Chem. 13, 952–962 (1992).ArticleÂ
CASÂ
Google ScholarÂ
Simmonett, A. C. & Brooks, B. R. A compression strategy for particle mesh Ewald theory. J. Chem. Phys. 154, 054112 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Pastore, M., Loro, P. A. D., Mingione, M. & Calcagni’, A. Overlapping: Estimation of Overlapping in Empirical Distributions. https://CRAN.R-project.org/package=overlapping (2022).Smorodina, E. Structural data for the antibody developability manuscript: cartography of developability landscapes in native and human-engineered antibodies. Zenodo https://doi.org/10.5281/zenodo.10013524 (2023).ArticleÂ
Google ScholarÂ